R-Smad signaling-mediated VEGF expression coordinately regulates endothelial cell differentiation of rat mesenchymal stem cells

Stem Cells and Development

Volumn 24, Issue 11, 2015, Pages 1320-1331

  Ai, Wen Jia ^a,b   Li, Jie ^b   Lin, Shao Mang ^a   Li, Wen ^b   Liu, Chi Zhuai ^b   Lv, Wei Ming ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 9; CD31 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; RECEPTOR REGULATED SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; GROWTH DIFFERENTIATION FACTOR 9; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; FLOW CYTOMETRY; INVESTIGATIVE PROCEDURES; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CYTOLOGY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GROWTH DIFFERENTIATION FACTOR 9; MALE; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SMAD PROTEINS, RECEPTOR-REGULATED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929580229     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0253     Document Type: Article

References (37)

1. Sekiya I, BL Larson, JR Smith, R Pochampally, JG Cui and DJ Prockop. (2002). Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20:530-541.
2. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
3. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
4. Zimmermann S, M Voss, S Kaiser, U Kapp, CF Waller and UM Martens. (2003). Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17:1146-1149.
5. Bernardo ME, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, D Montagna, R Maccario, R Villa, et al. (2007). Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142-9149.
6. Alhadlaq A and JJ Mao. (2004). Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13:436-448.
7. Parekkadan B and JM Milwid. (2010). Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 12:87-117.
8. Ringden O, M Uzunel, I Rasmusson, M Remberger, B Sundberg, H Lonnies, HU Marschall, A Dlugosz, A Szakos, et al. (2006). Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397.
9. Oswald J, S Boxberger, B Jorgensen, S Feldmann, G Ehninger, M Bornhauser and C Werner. (2004). Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377-384.
10. Zhang G, J Zhou, Q Fan, Z Zheng, F Zhang, X Liu and S Hu. (2008). Arterial-venous endothelial cell fate is related to vascular endothelial growth factor and Notch status during human bone mesenchymal stem cell differentiation. Febs Lett 582:2957-2964.
11. Shi Y and J Massague. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
12. Derynck R and YE Zhang. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584.
13. Massague J and YG Chen. (2000). Controlling TGF-beta signaling. Genes Dev 14:627-644.
14. David L and JJ Feige and S Bailly. (2009). Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20:203-212.
15. Goumans MJ, G Valdimarsdottir, S Itoh, A Rosendahl, P Sideras and DP Ten. (2002). Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Embo J 21:1743-1753.
16. Finnson KW, WL Parker, DP Ten, M Thorikay and A Philip. (2008). ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. J Bone Miner Res 23:896-906.
17. Konig HG, D Kogel, A Rami and JH Prehn. (2005). TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling. J Cell Biol 168:1077-1086.
18. Watabe T, A Nishihara, K Mishima, J Yamashita, K Shimizu, K Miyazawa, S Nishikawa and K Miyazono. (2003). TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. J Cell Biol 163:1303-1311.
19. Mallet C, D Vittet, JJ Feige and S Bailly. (2006). TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 24:2420-2427.
20. Goldman O, O Feraud, PJ Boyer-Di, C Driancourt, D Clay, MC Le Bousse-Kerdiles, A Bennaceur-Griscelli and G Uzan. (2009). A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells 27:1750-1759.
21. Bai H, Y Gao, M Arzigian, DM Wojchowski, WS Wu and ZZ Wang. (2010). BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway. J Cell Biochem 109:363-374.
22. Friedenstein AJ, UF Deriglasova, NN Kulagina, AF Panasuk, SF Rudakowa, EA Luria and IA Ruadkow. (1974). Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2:83-92.
23. Yamashita J, H Itoh, M Hirashima, M Ogawa, S Nishikawa, T Yurugi, M Naito, K Nakao and S Nishikawa. (2000). Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
24. Yamaguchi TP, DJ Dumont, RA Conlon, ML Breitman and J Rossant. (1993). flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489-498.
25. Nourse MB, DE Halpin, M Scatena, DJ Mortisen, NL Tulloch, KD Hauch, B Torok-Storb, BD Ratner, L Pabon and CE Murry. (2010). VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol 30:80-89.
26. James D, HS Nam, M Seandel, D Nolan, T Janovitz, M Tomishima, L Studer, G Lee, D Lyden et al. (2010). Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependent. Nat Biotechnol 28:161-166.
27. Kobayashi T, X Liu, FQ Wen, Q Fang, S Abe, XQ Wang, M Hashimoto, L Shen, S Kawasaki et al. (2005). Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts. Biochem Biophys Res Commun 327:393-398.
28. Nakagawa T, JH Li, G Garcia, W Mu, E Piek, EP Bottinger, Y Chen, HJ Zhu, DH Kang, et al. (2004). TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int 66:605-613.
29. Deckers MM, RL van Bezooijen, G van der Horst, J Hoogendam, C van Der Bent, SE Papapoulos and CW Lowik. (2002). Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143:1545-1553.
30. Liu Z, K Kobayashi, M van Dinther, SH van Heiningen, G Valdimarsdottir, T van Laar, M Scharpfenecker, CW Lowik, MJ Goumans, DP Ten and E Pardali. (2009). VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. J Cell Sci 122:3294-3302.
31. Ferrari G, BD Cook, V Terushkin, G Pintucci and P Mignatti. (2009). Transforming growth factor-beta 1 (TGFbeta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol 219:449-458.
32. Scharpfenecker M, M van Dinther, Z Liu, RL van Bezooijen, Q Zhao, L Pukac, CW Lowik and DP Ten. (2007). BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120:964-972.
33. Ferrara N, Gerber HP and J LeCouter. (2003). The biology of VEGF and its receptors. Nat Med 9:669-676.
34. Petersen M, E Pardali, G van der Horst, H Cheung, C van den Hoogen, G van der Pluijm and DP Ten. (2010). Smad 2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. Oncogene 29:1351-1361.
35. Xu J, X Liu, Y Jiang, L Chu, H Hao, Z Liua, C Verfaillie, J Zweier, K Gupta and Z Liu. (2008). MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med 12:2395-2406.
36. Feng XH and R Derynck. (2005). Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21:659-693.
37. Pardali E, MJ Goumans and DP Ten. (2010). Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 20:556-567.